good point re tax losses and market cap. the other side of buying losers is that unless you have a plan to profitability,you are buying a liability that will be a drag on the P&L.
Has BUBs ever turned a profit? have the BUBs issues with their former CEO been resolved? is there a risk of adverse publicity and litigation? maybe there are reasons why it's market cap is $100m.
I would rather see 100m.spent on marketing to the elderly/US FDA, US marketing and the release of new products ie the recent new formula release announcement
if Nestle etc pick up BUBs they will have a drain on their P&L and not much to show for it. Nestle market share in China is way behind A2M. Nestle is better off buying out A2M and actually getting to top 5 spot in China
Ann: 1H24 Results Presentation, page-72
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.86 |
Change
-0.240(3.38%) |
Mkt cap ! $4.948B | |||
| Open | High | Low | Value | Volume |
| $7.07 | $7.07 | $6.80 | $11.25M | 1.636M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23364 | $7.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.18 | 1018 | 1 |
View Market Depth
| Last trade - 15.59pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.85 |
Change
-0.240 ( 3.27 %) |
||||
| Open | High | Low | Volume | ||
| $7.05 | $7.06 | $6.81 | 722232 | ||
| Last updated 15.59pm 12/06/2024 ? | |||||
| A2M (ASX) Chart |